Seegene, Inc. (KOSDAQ: A096530)
Health Care · Biotechnology · KR
₩38,150.00
+3.39% today · +52.9% 1Y
Seegene, Inc. (KOSDAQ: A096530) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.29B.
Over the last twelve months the share price has gained 52.9%, trading between 21.70K and 40.45K.
Tweenvest scores Seegene, Inc. across four factors: quality 70/100, value 33/100, growth 50/100, dividend 91/100. Its strongest factor is dividend.
A096530 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.29B
- Revenue (TTM)
- $328.86M
- P/E
- 19.09
- EPS
- 1,998.06
- Dividend yield
- 2.62%
- Beta (5Y)
- 0.90
- 52-week high
- ₩40,450.00
- 52-week low
- ₩21,700.00
- Avg volume (3M)
- —
- Shares outstanding
- 45.56M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Damora Therapeutics, Inc.NasdaqCM: DMRA | $1.30B | $20.22 | -4.08% |
| Liaoning Chengda Biotechnology Co., Ltd.SHSE: 688739 | $1.30B | CN¥21.20 | +0.86% |
| Vcanbio Cell & Gene Engineering Corp., LtdSHSE: 600645 | $1.30B | CN¥19.10 | +2.25% |
| Vitrolife AB (publ)OM: VITR | $1.29B | Skr95.20 | -0.42% |
| Replimune Group, Inc.NasdaqGS: REPL | $1.26B | $13.06 | -2.68% |
| Daan Gene Co., Ltd.SZSE: 002030 | $1.26B | CN¥6.03 | +4.87% |
| Savara Inc.NasdaqGS: SVRA | $1.25B | $4.85 | -1.52% |
| ORIC Pharmaceuticals, Inc.NasdaqGS: ORIC | $1.24B | $11.75 | -2.00% |
Figures last refreshed Oct 11, 2026.